Fluorine-18

From WikiMD's WELLNESSPEDIA

Fluorine-18 is a radioisotope of fluorine that is commonly used in medical imaging. It is a positron emitter with a half-life of 109.77 minutes.

Production[edit]

Fluorine-18 is produced in a cyclotron by bombarding a target, usually oxygen-18 enriched water, with high-energy protons. The reaction that takes place is a proton knockout reaction, where a proton is knocked out of the oxygen nucleus, and a neutron is left in its place, resulting in the production of fluorine-18.

Uses[edit]

The primary use of fluorine-18 is in the production of radiopharmaceuticals for positron emission tomography (PET) scans. The most commonly used of these is fluorodeoxyglucose (FDG), which is used to measure metabolic activity in tissues. This is particularly useful in oncology, where it can be used to identify areas of increased metabolic activity, which may indicate the presence of a tumor.

Fluorine-18 can also be used in the production of other radiopharmaceuticals, such as flumazenil, which is used in the diagnosis of epilepsy, and flutemetamol, which is used in the diagnosis of Alzheimer's disease.

Safety[edit]

As a radioactive substance, fluorine-18 must be handled with care to avoid unnecessary exposure. However, its short half-life means that it decays quickly, reducing the risk of long-term exposure. In addition, the positrons it emits are quickly annihilated, producing gamma rays that can be easily shielded against.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.